Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.

[1]  A. Matsuda,et al.  In vitro and in vivo antitumor activity of a novel nucleoside, 4'-thio-2'-deoxy-2'-methylidenecytidine. , 1996, Biological & pharmaceutical bulletin.

[2]  Y. Yoshimura,et al.  Comparison of the Selectivity of Anti‐Varicella‐Zoster Virus Nucleoside Analogues , 1995, Microbiology and immunology.

[3]  M. Almond,et al.  Varicella-zoster virus thymidine kinase. Characterization and substrate specificity. , 1993, Biochemical pharmacology.

[4]  T. Suzutani,et al.  Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase. , 1993, The Journal of general virology.

[5]  A. Matsuda,et al.  In vitro Anti-Herpesvirus Activities of 5-Substituted 2′-Deoxy-2′-Methylidene Pyrimidine Nucleosides , 1993 .

[6]  K. Powell,et al.  5-Alkynyl Pyrimidine Nucleosides as Potent Selective Inhibitors of Varicella-Zoster Virus , 1992 .

[7]  M. Young,et al.  Synthesis and antiviral activity of 1-cyclobutyl-5-(2-bromovinyl)uracil nucleoside analogues and related compounds. , 1992, Journal of medicinal chemistry.

[8]  K. Powell,et al.  Random mutagenesis of the thymidine kinase gene of varicella-zoster virus , 1992, Journal of virology.

[9]  T. Suzutani,et al.  Different Antiviral Potencies of BV‐araU and Related Nucleoside Analogues against Herpes Simplex Virus Type 1 in Human Cell Lines and Vero Cells , 1991, Microbiology and immunology.

[10]  R. T. Walker,et al.  The synthesis and antiviral activity of some 4'-thio-2'-deoxy nucleoside analogues. , 1991, Journal of medicinal chemistry.

[11]  M. Niimura,et al.  Clinical effect of BV-araU on varicella-zoster virus infection in immunocompromised patients with haematological malignancies. , 1991, The Journal of antimicrobial chemotherapy.

[12]  H. Machida,et al.  Inhibition of DNA Synthesis in Varicella‐Zoster Virus‐Infected Cells by BV‐araU , 1991, Microbiology and immunology.

[13]  G. Gentry,et al.  Herpesviral deoxythymidine kinases contain a site analogous to the phosphoryl-binding arginine-rich region of porcine adenylate kinase; comparison of secondary structure predictions and conservation. , 1990, The Journal of general virology.

[14]  H. Machida,et al.  Drug Susceptibilities of Isolates of Varicella‐Zoster Virus in a Clinical Study of Oral Brovavir , 1990, Microbiology and immunology.

[15]  H. Machida.  In vitro anti-herpes virus action of a novel antiviral agent, brovavir (BV-araU). , 1990 .

[16]  T. Yokota,et al.  Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. , 1989, Molecular pharmacology.

[17]  H. Machida.  Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs , 1986, Antimicrobial Agents and Chemotherapy.

[18]  E. De Clercq,et al.  Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus. , 1983, The Journal of infectious diseases.

[19]  J. A. Fyfe.  Differential phosphorylation of (E)-5-(2-bromovinyl)-2'-deoxyuridine monophosphate by thymidylate kinases from herpes simplex viruses types 1 and 2 and varicella zoster virus. , 1982, Molecular pharmacology.

[20]  H. Schaeffer,et al.  Enzymatic phosphorylation of acyclic nucleoside analogs and correlations with antiherpetic activities. , 1981, Biochemical pharmacology.

[21]  R. T. Walker,et al.  Differential affinities of 5-(2-halogenovinyl)-2'-deoxyuridines for deoxythymidine kinases of various origins. , 1981, Molecular pharmacology.

[22]  T. Hackstadt,et al.  Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase , 1979, Journal of virology.

[23]  T. Ogino,et al.  Induction of deoxypyrimidine kinase activity in human embryonic lung cells infected with varicella-zoster virus , 1977, Journal of virology.

[24]  Y. Cheng,et al.  Human deoxythymidine kinase. I. Purification and general properties of the cytoplasmic and mitochondrial isozymes derived from blast cells of acute myelocytic leukemia. , 1976, The Journal of biological chemistry.